Expectations, symptoms, and quality of life before and after 1 year of Pirfenidone treatment in patients with idiopathic pulmonary fibrosis: A single‐arm, open‐label nonrandomized study

BACKGROUND AND AIMS: Antifibrotic therapies reduce lung function decline in patients with idiopathic pulmonary fibrosis (IPF). This single‐arm, open‐label, nonrandomized study aimed to determine the influence of antifibrotic treatment on patients' reported symptoms and expectations of the thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Jastrzębski, Dariusz, Kostorz‐Nosal, Sabina, Galle, Dagmara, Gałeczka‐Turkiewicz, Alicja, Warzecha, Joanna, Majewski, Sebastian, Piotrowski, Wojciech J., Ziora, Dariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432581/
https://www.ncbi.nlm.nih.gov/pubmed/37599655
http://dx.doi.org/10.1002/hsr2.1449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432581/
https://www.ncbi.nlm.nih.gov/pubmed/37599655
http://dx.doi.org/10.1002/hsr2.1449

Ejemplares similares